Skip to content

Study on the efficacy of drug therapy for otomycosis

Study on the efficacy of drug therapy for otomycosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127349
Enrollment
Unknown
Registered
2026-06-30
Start date
2025-04-21
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otomycosis

Interventions

Pirensong Cream Group:Triamcinolone acetonide 0.1% + Econazole nitrate 1% cream
Clear deep ear canal crusts, local irrigation in external auditory canal, once every 7 days, 2ml each time
Quimixin Cream Group:Triamcinolone acetonide 0.1% + Miconazole 1% + Neomycin 0.2% cream
Same as control group (clear deep ear canal crusts, local irrigation in external auditory canal, once every 7 days, 2ml each time)
Pirensong Cream Group (No Cleaning):Triamcinolone acetonide 0.1% + Econazole nitrate 1% cream
No clearing of deep ear canal crusts, local irrigation in external auditory canal, once every 7 days, 2ml each time
Terbinafine Hydrochloride Group:Terbinafine hydrochloride cream or spray

Sponsors

Qingdao Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 81 Years

Inclusion criteria

Inclusion criteria: 1. Symptomatic patients with characteristic fungal membrane-like substances, hyphae or spores in the ear canal and positive fungal culture results; 2. No local or systemic antifungal treatment was received within 4 weeks before enrollment.

Exclusion criteria

Exclusion criteria: 1. Contraindications to the study drugs; 2. Comorbidity with uncontrolled underlying diseases; 3. Concurrent tympanic cavity infection; 4. Poor patient compliance; 5. Pregnant or lactating females.

Design outcomes

Primary

MeasureTime frame
Efficacy evaluation;

Secondary

MeasureTime frame
Symptom and sign scoring;Onset of action and drug clearance time;

Countries

China

Contacts

Public ContactDu Guoqiang

Qingdao Municipal Hospital

dugq2020@163.com+86 176 6965 7139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026